Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Aug 30, 2023 7:33am
134 Views
Post# 35611405

LABS has the licenses from EPM on the acid forms, NOT their

LABS has the licenses from EPM on the acid forms, NOT theirpharma partner or any other pharma customer.   That's been told to us by LABS in carefully worded comments.  

...this is WHY a global pharmaceutical company is their partner
...this is WHY LABS can say we manufacture advanced derivative forms
...this is WHY Pidduck said, we have a plan to generate cash in the near term


How much of them does Pfizer want?  $5 Billion, $10 Billion, $20 Billion....?

Hang on people, we have a lot of peace and tranquility coming our way because life on this Planet is structured like a sh*t sandwich and the more bread you have the less sh*t you have to eat.


<< Previous
Bullboard Posts
Next >>